Sexual Health News

CHICAGO — HPV vaccination rates for children and young adults increased substantially during the 2010s regardless of gender, race or ethnicity, according to findings presented at ASCO Annual Meeting.

In a phase 2b study, select healthy premenopausal women with sexual arousal disorder who received topical sildenafil cream reported improvements across multiple aspects of sexual function compared with those who received placebo cream.

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

Researchers find that while clinicians agree on diagnostic and treatment practices for pediatric vulvar and perianal lichen sclerosus, management techniques lack uniformity, according to a study.

Mode of delivery did not affect self-perceived sexual life satisfaction overall or at any time postpartum, according to cohort study results published in the American Journal of Obstetrics and Gynecology.

Women who use contraceptive pills may be at a higher risk for frontal fibrosing alopecia, according to a study.

SAN FRANCISCO — Targeted routine syphilis screening may help identify pregnant women in the first and third trimester in need of treatment compared with universal screening, researchers reported.

BOSTON — In a phase 2b trial, a hormonal contraceptive gel for use by men worked faster than expected, suppressing sperm count to effective levels by week 8 of use, making it an “attractive” product, according to a speaker at ENDO 2024.

WHO reported a “major” increase in STIs in 2022, specifically highlighting an increase in syphilis and an insufficient decline in new HIV and viral hepatitis infections.

A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.